The rise of a new psychoactive agent: Salvia divinorum

International Journal of Mental Health and Addiction

Volumn 5, Issue 3, 2007, Pages 248-253

  Appel, Jonathan ^a   Kim Appel, Dohee ^b  

^a Bridgewater House   (United States)

^b Firelands Counseling and Recovery Services   (United States)

Author keywords

Drugs of abuse; Hallucinogen; Herbal drugs; Kappa opioid receptor; Recreational drugs; Salvia; Salvia divinorum; Salvinorin A

Indexed keywords

EID: 34547827998     PISSN: 15571874     EISSN: 15571882     Source Type: Journal    
DOI: 10.1007/s11469-007-9086-4     Document Type: Article

References (28)

1. Baggott, M. J., Erowid, E., Erowid, F., & Mendelson, J. E. (2004). Use of salvia divinorum, an unscheduled hallucinogenic plant: A web-based survey of 500 users. Clinical Pharmacology and Therapeutics 75, 72.
2. Chavkin, C., Sud, S., Jin, W., Stewart, J., Zjawiony, J. K., Siebert, D. J., et al. (2004). Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum, is a highly efficacious kappa opioid receptor agonist: Structural and functional considerations. The Journal of Pharmacology and Experimental Therapeutics, 308(3), 1197-1203.
3. Devine, D. P., Leone, P., Pocock, D., & Wise, R. A. (1993). Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. The Journal of Pharmacology and Experimental Therapeutics, 266, 1236-1246.
4. Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. The Proceedings of the National Academy of Sciences of the USA, 85, 5274-5278.
5. Donzanti, B. A., Althaus, J. S., Payson, M. M., & Von Voigtlander, P. F. (1992). Kappa agonist-induced reduction in dopamine release: Site of action and tolerance. Research Communications in Chemical Pathology and Pharmacology, 78, 193-210.
6. Drug Enforcement Administration. (2007). List of drugs and chemicals of concern. Internet website: http://www.deadiversion.usdoj.gov/drugs_concern/ salvia_d/salvia_d.htm.
7. Epling, C., & Játiva-M, C. D. (1962). A new species of salvia from Mexico. Botanical Museum. Leaflets Harvard University, 20, 75-76.
8. Glick, S. D., Maisonneuve, I. M., Raucci, J., & Archer S. (1995). Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Research, 681, 147-152.
9. González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J. (2006). Pattern of use and subjective effects of salvia divinorum among recreational users. Drug and Alcohol Dependence, 85(2), 157-162.
10. Haynes, K. R. (2001). Antidepressant effects of the herb salvia divinorum: A case report. Journal of Clinical Psychopharmacology, 21(6), 634-635.
11. Kuzmin, A. V., Semenova, S., Gerrits, M., Zvartau, E. E., & Van Ree, J. M. (1997). K-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naïve rats and mice. European Journal of Pharmacology, 321, 265-271.
12. Prisinzano, T. E. (2005). Psychopharmacology of the hallucinogenic sage salvia divinorum. Life Sciences, 78(5), 527-531.
13. Rey, J, & Tennant, C. (2002). Cannabis and mental health. British Medical Journal, 325, 1183-1184.
14. Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman R. B. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences of the USA, 99(18), 11934-11939.
15. Schaper D. (2006). National Public Radio: Legal, herbal hallucinogenic draws teens, critics. Radio broadcast Washington, DC: NPR.
16. Schenk, S., Partridge, B., & Shippenberg, T. S. (1999). U69593, a kappaopioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology, 144, 339-346.
17. Sheffler, D. J., & Roth, B. L. (2003). Salvinorin A: The 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor. Trends in Pharmacological Sciences, 24(3), 107-109.
18. Siebert, D. (1994). Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology, 43, 53-56.
19. Spanagel, R., Herz, A., & Shippenberg, T. S. (1992). Opposing tonically active endogeneous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the USA, 89, 2046-2050.
20. Ukai, M., Suzuki, M., & Mamiya, T. (2002). Effects of U-50, 488H, a kappa opioid receptor agonist, on the learned helplessness model of depression in mice. Journal of Neural Transmission, 109, 1221-1225.
21. Valdés, L. J. III (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. Journal of Psychoactive Drugs, 26, 277-283.
22. Valdes, L. J. III, Diaz, J., & Paul, A. G. (1983). Ethnopharmacology of ska maria pastora (Salvia divinorum, Epling and Játiva-M.). Journal of Ethnopharmacology, 7, 287-312.
23. Valdes, L. J. III, Butler, W. B., Hatfield, G. M., Paul, A. G., & Koreeda M. (1984). Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, salvia divinorum. Journal of Organic Chemistry, 49, 4716-4720.
24. Walsh, S. K., Geter-Douglas, B., Strain, E. C., Bigelow, G. E. (2001). Enadoline and butorphanol: Evaluation of k-agonist on cocaine pharmacodynamics and cocaine self-administration in humans. Pharmacology, 299, 147-158.
25. Wasson, R. G. (1962). A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets Harvard University, 20, 77-84.
26. Wasson, R. G. (1963). Notes on the present status of ololiuhqui and the other hallucinogens of Mexico. Botanical Museum Leaflets Harvard University, 20, 161-193.
27. Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2005). Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: Agonist actions at kappa opioid receptors. Psychopharmacology, 179, 551-558.
28. Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2004). Effect of the k- opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology, 173, 146-152.